Amgen pipeline:AMGEN OUTLINES GROWTH STRATEGY THROUGH ...

AMGEN OUTLINES GROWTH STRATEGY THROUGH ...

AMGEN OUTLINES GROWTH STRATEGY THROUGH ...

2022年2月8日—Phase3dataforbiosimilarstoSTELARA®(ustekinumab),SOLIRIS®(eculizumab),andEYLEA®(aflibercept)areexpectedin2022;Amgen'spipeline ...。其他文章還包含有:「AmgenPipeline」、「OurPipeline」、「ProductPipeline」、「Science」

查看更多 離開網站